Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis

Xiaojing Song; Fanghui  Ding; Wei Luo; Juan Tao; Kaili Yang; Qiaoping Li; Zhitao Zhang

doi:10.18388/abp.2020_6319

Xiaojing Song Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, China https://orcid.org/0000-0001-9462-0056
Fanghui Ding Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, China
Wei Luo Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, China
Juan Tao The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, China
Kaili Yang The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, China
Qiaoping Li The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, China
Zhitao Zhang The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, 730000, China

DOI: https://doi.org/10.18388/abp.2020_6319

Abstract

Hepatocellular carcinoma (HCC) has high mortality and incidence worldwide. The molecular mechanism associated with HCC is largely unexplored. Objective: To investigate the impact of CD44 knock-down on the proliferation, migration, and invasiveness in HCC cells. Methods: Colony formation and MTT assay were used to observe cellular proliferation and viability. In addition, cellular invasion and migration were studied by Transwell and wound healing assays respectively. Finally, western blotting was utilized to check the protein expression levels. Results: The cellular proliferation, invasion and metastasis in Huh7 cells were inhibited after the silencing of CD44. Furthermore, expression levels of MMP-2, MMP-9, CXCR4, GSK-3β and β-catenin was significantly decreased. However, opposite results were demonstrated when CD44 was overexpressed. Conclusions: Interference with the expression of CD44 significantly inhibits the invasion and metastasis in the HCC cell line, Huh7. Furthermore, CD44 was found to regulate the expression of MMP-2, MMP-9, CXCL12, CXCR4 and Wnt/β-catenin signal pathway.